跳至主要内容
临床试验/EUCTR2006-000995-33-GB
EUCTR2006-000995-33-GB进行中(未招募)1 期

First International Inter-Group Study for Classical Hodgkin’s Lymphoma in Children and Adolescents - EuroNet-PHL-C1

Martin Luther University of Hallle/Wittenburg0 个研究点目标入组 1,200 人开始时间: 2007年10月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • •Diagnosis of classic Hodgkin’s lymphoma
  • •Patient aged under 18 years at time of diagnosis
  • •Written informed consent of the patient and/or the patient’s parents or guardian according to national laws
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) no
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) no
  • •F.1.3.1 Number of subjects for this age range

排除标准

  • •Pre-treatment of Hodgkin’s lymphoma differing from study protocol (except recommended pre-phase therapy of a large mediastinal tumour)
  • •Known hypersensitivity or contraindication to study drugs
  • •Diagnosis of lymphocyte predominant Hodgkin’s lymphoma
  • •Prior chemotherapy or radiotherapy
  • •Other (simultaneous) malignancies
  • •Pregnancy and / or lactation
  • •Females who are sexually active refusing to use effective contraception (oral contraception, intrauterine devices, barrier method of contraception in conjunction with spermicidal jelly or surgical sterile)
  • •Current or recent (within 30 days prior to start of trial treatment) treatment with another investigational drug or participation in another investigational trial
  • •Severe concomitant diseases (e.g. immune deficiency syndrome)
  • •Known HIV positivity

研究者

发起方
Martin Luther University of Hallle/Wittenburg

相似试验